International regulatory harmonization through consistent regulations and risk assessment guidelines across countries could help to overcome challenges and potential delays in the development and commercialization of double-stranded RNA (dsRNA)-based biopesticides.
- Sandya Gunasekara
- Pedro Fidelman
- Neena Mitter
